Michael Aaron Kelly - Director at Neogenomics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
NEO on Nasdaq
Industry
Services-Testing Laboratories
All Insider Reports
All Insider Reports

Michael Aaron Kelly - trading volume in the past year for Neogenomics Inc

Holdings reported by Michael Aaron Kelly for Neogenomics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 44K $339K $7.70 Jun 1, 2025 Direct
Restricted Stock Unit 12.3K $193K $15.74 Jun 1, 2024 Direct Common Stock
Restricted Stock Unit 23.1K $126K $10.27 Jun 1, 2025 Direct Common Stock 12.3K
Stock Option (Right to Buy) 16.1K $89.1K $10.27 Jun 1, 2025 Direct Common Stock 8.67K
Common Stock 5K $38.5K $7.70 Jun 1, 2025 M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016

Transactions reported by Michael Aaron Kelly for Neogenomics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.